Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Comments on - vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.

Krishnamurthy S, Pathy S, Ahmed I, Chander S.

Radiother Oncol. 2014 Dec;113(3):426. doi: 10.1016/j.radonc.2014.05.006. Epub 2014 Jun 12. No abstract available.

PMID:
24931293
2.

Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.

Westerveld H, Pötter R, Berger D, Dankulchai P, Dörr W, Sora MC, Pötter-Lang S, Kirisits C.

Radiother Oncol. 2013 Apr;107(1):99-105. doi: 10.1016/j.radonc.2013.04.009. Epub 2013 Apr 29.

3.

Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results.

Lei X, Qian CY, Qing Y, Zhao KW, Yang ZZ, Dai N, Zhong ZY, Tang C, Li Z, Gu XQ, Zhou Q, Feng Y, Xiong YL, Shan JL, Wang D.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1264-70. doi: 10.1016/j.ijrobp.2010.08.039. Epub 2011 Mar 23.

PMID:
21435797
4.

Optimizing brachytherapy for locally advanced cervical cancer.

Niël CG, Koper PC, Visser AG, Sipkema D, Levendag PC.

Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):873-7.

PMID:
8040037
5.

Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses.

Fidarova EF, Berger D, Schüssler S, Dimopoulos J, Kirisits C, Georg P, Bachtiary B, Pötter R.

Radiother Oncol. 2010 Oct;97(1):76-9. doi: 10.1016/j.radonc.2010.05.005. Epub 2010 Jun 17.

PMID:
20561694
6.

Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.

Westerveld H, de Leeuw A, Kirchheiner K, Dankulchai P, Oosterveld B, Oinam A, Hudej R, Swamidas J, Lindegaard J, Tanderup K, Pötter R, Kirisits C; EMBRACE Collaborative Group.

Radiother Oncol. 2016 Sep;120(3):420-427. doi: 10.1016/j.radonc.2016.05.002. Epub 2016 May 26.

PMID:
27237058
7.

Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.

Toita T, Kakinohana Y, Ogawa K, Adachi G, Moromizato H, Nagai Y, Maehama T, Sakumoto K, Kanazawa K, Murayama S.

Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1344-53.

PMID:
12873679
8.

Comparative analysis of rectal dose parameters in image-guided high-dose-rate brachytherapy for cervical cancer with and without a rectal retractor.

Gaudet M, Lim P, Yuen C, Zhang S, Spadinger I, Dubash R, Aquino-Parsons C.

Brachytherapy. 2014 May-Jun;13(3):257-62. doi: 10.1016/j.brachy.2014.01.001. Epub 2014 Jan 28.

PMID:
24480263
9.

Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator.

Berger D, Dimopoulos J, Georg P, Georg D, Pötter R, Kirisits C.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1451-9. Epub 2007 Feb 7.

PMID:
17289290
11.

Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.

Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst J, Koelbl H, Haensgen G.

Strahlenther Onkol. 2002 Jul;178(7):378-85.

PMID:
12163992
12.

High-dose-rate brachytherapy for vaginal cancer: learning from treatment complications.

Tyree WC, Cardenes H, Randall M, Papiez L.

Int J Gynecol Cancer. 2002 Jan-Feb;12(1):27-31.

PMID:
11860533
13.

The irradiation tolerance dose of the proximal vagina.

Au SP, Grigsby PW.

Radiother Oncol. 2003 Apr;67(1):77-85.

PMID:
12758243
14.

Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.

Budrukkar AN, Shrivastava SK, Jalali R, Agarwal JP, Deshpande DD, Nehru RM, Dinshaw KA.

Strahlenther Onkol. 2001 Oct;177(10):517-24.

PMID:
11680016
15.

Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.

Zhang M, Xu HD, Pan SD, Lin S, Yue JH, Liu JR.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):966-71. doi: 10.1016/j.ijrobp.2011.08.031. Epub 2011 Dec 3.

PMID:
22138462
16.

Intermediate-term results of image-guided brachytherapy and high-technology external beam radiotherapy in cervical cancer: Chiang Mai University experience.

Tharavichitkul E, Chakrabandhu S, Wanwilairat S, Tippanya D, Nobnop W, Pukanhaphan N, Galalae RM, Chitapanarux I.

Gynecol Oncol. 2013 Jul;130(1):81-5. doi: 10.1016/j.ygyno.2013.04.018. Epub 2013 Apr 17.

PMID:
23603369
17.

Interstitial brachytherapy in the management of primary carcinoma of the cervix and vagina.

Nag S, Martínez-Monge R, Selman AE, Copeland LJ.

Gynecol Oncol. 1998 Jul;70(1):27-32.

PMID:
9698469
18.

A modified technique for high-dose-rate intracavitary brachytherapy in advanced cancer of the cervix.

Sharma V, Mahantshetty U, Menon V, Sharma D.

Brachytherapy. 2003;2(4):246-8.

PMID:
15062133
19.

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.

Petereit DG, Sarkaria JN, Potter DM, Schink JC.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1267-74.

PMID:
10613322
20.

MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.

Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J.

Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):756-64. doi: 10.1016/j.ijrobp.2007.10.032. Epub 2008 Jan 11.

PMID:
18191335

Supplemental Content

Support Center